AptarGroup (Aptar) said that its Unidose Powder System has been approved by the US Food and Drug Administration (FDA) for
The post Aptar wins FDA approval for Unidose Powder System for nasal spray of hypoglycemia drug appeared first on PharmaNewsDaily.com.
Boston-based biopharma company Proteostasis Therapeutics has dosed the first patient in a phase 2 clinical trial of its cystic fibrosis
The post Proteostasis begins dosing in phase 2 cystic fibrosis trial appeared first on PharmaNewsDaily.com.
Baqsimi FDA approval : Eli Lilly and Company (Lilly) has secured the US Food and Drug Administration (FDA) approval) for
The post Lilly secures Baqsimi FDA approval for severe hypoglycemia appeared first on PharmaNewsDaily.com.
